<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: adverse drug reactions</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Recent increase in adverse TMP-SMX reactions in children</title>
   	 <description>(HealthDay)—There has been a significant increase in adverse drug reactions (ADRs) associated with use of trimethoprim-sulfamethoxazole (TMP-SMX) for treatment of skin and soft tissue infection (SSTI) in children, according to research published online Dec. 3 in Pediatrics.</description>
     <link>http://medicalxpress.com/news/2012-12-adverse-tmp-smx-reactions-children.html</link>
	 <category>Pediatrics</category>
	 <pubDate>Mon, 03 Dec 2012 17:30:01 EST</pubDate>
	 <guid isPermaLink="false">news273776362</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/recentincrea.jpg" width="90" height="90" />
</item>
<item>
     <title>BMJ editor urges Roche to fulfil promise to release Tamiflu trial data</title>
   	 <description>In an open letter to company director, Professor Sir John Bell, she says: &quot;Billions of pounds of public money have been spent on [Tamiflu] and yet the evidence on its effectiveness and safety remains hidden from appropriate and necessary independent scrutiny.&quot;</description>
     <link>http://medicalxpress.com/news/2012-10-bmj-editor-urges-roche-fulfil.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 30 Oct 2012 14:10:02 EST</pubDate>
	 <guid isPermaLink="false">news270824257</guid>
	 
</item>
<item>
     <title>Parent-clinician communication about children's drug reactions needs improvement</title>
   	 <description>Many parents are dissatisfied with communication regarding adverse drug reactions experienced by their child, and the implications of such reactions for the child's future use of medicines, according to a new study published Oct. 10 in the open access journal PLOS ONE by Bridget Young from the University of Liverpool, UK and colleagues.</description>
     <link>http://medicalxpress.com/news/2012-10-parent-clinician-children-drug-reactions.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 10 Oct 2012 17:00:22 EST</pubDate>
	 <guid isPermaLink="false">news269106397</guid>
	 
</item>
<item>
     <title>Profs aim to track drug reactions via social media</title>
   	 <description>Experiencing nausea, headaches or other side effects from prescriptions or over-the-counter medicines? Researchers say tweeting about it or posting your concerns online could one day help alert drug companies and federal regulators to problems more quickly—potentially saving lives and money.</description>
     <link>http://medicalxpress.com/news/2012-10-profs-aim-track-drug-reactions.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 03 Oct 2012 17:50:02 EST</pubDate>
	 <guid isPermaLink="false">news268504405</guid>
	 
</item>
<item>
     <title>New discovery could lead to new way to screen drugs for adverse reactions</title>
   	 <description>Adverse drug reactions are a major issue that cause harm, are costly and restrict treatment options for patients and the development of new drugs. A groundbreaking finding by researchers from the La Jolla Institute for Allergy &amp; Immunology could lead to a new way to dramatically improve drug safety by identifying drugs at risk to cause potentially fatal genetic-linked hypersensitivity reactions before their use in man.</description>
     <link>http://medicalxpress.com/news/2012-05-discovery-screen-drugs-adverse-reactions.html</link>
	 <category>Immunology</category>
	 <pubDate>Tue, 29 May 2012 09:52:34 EST</pubDate>
	 <guid isPermaLink="false">news257503911</guid>
	 
</item>
<item>
     <title>ICD-9 codes underestimate statin-linked rhabdomyolysis</title>
   	 <description>(HealthDay) -- Use of diagnostic codes, such as International Classification of Diseases -- Ninth Revision (ICD-9) codes, may result in misclassification of rare, adverse drug reactions (ADRs), including the risk of rhabdomyolysis from high-dose simvastatin, according to a research letter published in the April 18 issue of the Journal of the American Medical Association, a theme issue on comparative effectiveness research.</description>
     <link>http://medicalxpress.com/news/2012-04-icd-codes-underestimate-statin-linked-rhabdomyolysis.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 18 Apr 2012 01:20:01 EST</pubDate>
	 <guid isPermaLink="false">news253928794</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/ltigticd9lti.jpg" width="90" height="90" />
</item>
<item>
     <title>Kids' penicillin allergy may not signal other drug reactions</title>
   	 <description>(HealthDay) -- Children who are allergic to penicillin are not more likely than other kids to develop additional drug allergies, new research suggests.</description>
     <link>http://medicalxpress.com/news/2012-03-kids-penicillin-allergy-drug-reactions.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Thu, 08 Mar 2012 04:40:02 EST</pubDate>
	 <guid isPermaLink="false">news250403088</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/kidspenicill.jpg" width="90" height="90" />
</item>
<item>
     <title>Study evaluates antibiotic option for treating bladder infection in women</title>
   	 <description>Short-term use of the antibiotic cefpodoxime for the treatment of women with uncomplicated cystitis (bladder infection) did not meet criteria for noninferiority for achieving clinical cure compared with ciprofloxacin, a drug in the fluoroquinolone class of antibiotics for which there have been concerns about overuse and a resulting increase in resistance rates, according to a study in the February 8 issue of JAMA. The criteria for noninferiority was if the efficacy of cefpodoxime had been shown to be within a pre-specified margin of 10 percent of the efficacy of ciprofloxacin.</description>
     <link>http://medicalxpress.com/news/2012-02-antibiotic-option-bladder-infection-women.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 07 Feb 2012 16:41:24 EST</pubDate>
	 <guid isPermaLink="false">news247855241</guid>
	 
</item>
<item>
     <title>Taking a predictive approach to identifying adverse drug reactions</title>
   	 <description>In a move aimed at bolstering current systems for assessing and monitoring drug safety, researchers at Children's Hospital Boston have created a new method that combines multiple forms of widely available data to predict adverse drug reactions. Unlike current approaches, which rely on detecting evidence of drug safety issues as they accumulate over time in clinical databases, this new method may be able to identify issues years in advance.</description>
     <link>http://medicalxpress.com/news/2011-12-approach-adverse-drug-reactions.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 21 Dec 2011 14:00:04 EST</pubDate>
	 <guid isPermaLink="false">news243694936</guid>
	 
</item>
<item>
     <title>Vascular risk linked to long-term antiepileptic drug therapy</title>
   	 <description>New research reveals that patients with epilepsy who were treated for extended periods with older generation antiepileptic drugs (AEDs) may be at increased risk for developing atherosclerosis, a common disorder known as hardening of the arteries. According to the findings now available in Epilepsia, the journal of the International League Against Epilepsy (ILAE), the vascular risk is significantly associated with the duration of AED monotherapy.</description>
     <link>http://medicalxpress.com/news/2011-11-vascular-linked-long-term-antiepileptic-drug.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 15 Nov 2011 04:10:03 EST</pubDate>
	 <guid isPermaLink="false">news240551375</guid>
	 
</item>
<item>
     <title>Many adverse drug reactions among hospital and emergency care patients are preventable</title>
   	 <description>Hyderabad, India: Many cases of adverse drug reactions (ADRs) seen in hospital and emergency care could be prevented, says a new study to be presented to the annual conference of the International Pharmaceutical federation (FIP) tomorrow (Thursday) . The researchers who carried out the study say that the finding that preventable ADRs are so widespread has important implications for healthcare systems.</description>
     <link>http://medicalxpress.com/news/2011-09-adverse-drug-reactions-hospital-emergency.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 07 Sep 2011 04:20:20 EST</pubDate>
	 <guid isPermaLink="false">news234588012</guid>
	 
</item>
<item>
     <title>Everyday medicines can destroy lives, conference warns</title>
   	 <description>Experts have called for increased awareness about the issue of adverse drug reactions after hearing how everyday prescription medicines are destroying the lives of some patients.</description>
     <link>http://medicalxpress.com/news/2011-07-everyday-medicines-conference.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 07 Jul 2011 13:24:57 EST</pubDate>
	 <guid isPermaLink="false">news229263872</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/everydaymedi.jpg" width="90" height="90" />
</item>
<item>
     <title>Pharmacogenetics testing offers way to reduce deaths from drug toxicity</title>
   	 <description>On average, a drug on the market works effectively for only 50% of the people who take it. Would you want to prevent a potential adverse drug effect or even toxicity through a simple test? It's not science fiction, but a reality. Pharmacogenetics (PGx) is the study of an individual's variation in DNA sequence related to drug response. The goal is to select the right drug at the right dose, and to avoid adverse drug reactions or ineffective treatment.</description>
     <link>http://medicalxpress.com/news/2011-04-pharmacogenetics-deaths-drug-toxicity.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 11 Apr 2011 11:51:19 EST</pubDate>
	 <guid isPermaLink="false">news221741469</guid>
	 
</item>
<item>
     <title>Frailty not a factor in adverse drug reactions among seniors, study finds</title>
   	 <description>Contrary to popular belief among physicians, frailty in elderly patients is not associated with an increased risk of adverse reactions to medications, according to a study led by Michael Steinman, MD, a geriatrician at the San Francisco VA Medical Center.</description>
     <link>http://medicalxpress.com/news/2011-04-frailty-factor-adverse-drug-reactions.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 07 Apr 2011 09:48:20 EST</pubDate>
	 <guid isPermaLink="false">news221388479</guid>
	 
</item>


</channel>
</rss>
